Abstract

This prospective study defines expected US elastography measurement variability to guide clinical interpretation, enable diagnostic enrichment in clinical trials, and support U.S. Food and Drug Administration biomarker validation for nonalcoholic fatty liver disease.

Keywords:
Medicine Nonalcoholic fatty liver disease Transient elastography Reproducibility Repeatability Shear (geology) Transient (computer programming) Biomedical engineering Radiology Pathology Fatty liver Disease Internal medicine Cirrhosis Composite material Statistics Liver fibrosis

Metrics

25
Cited By
23.04
FWCI (Field Weighted Citation Impact)
36
Refs
0.99
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Liver Disease Diagnosis and Treatment
Health Sciences →  Medicine →  Epidemiology
Cardiovascular Disease and Adiposity
Health Sciences →  Medicine →  Cardiology and Cardiovascular Medicine
Lipid metabolism and disorders
Health Sciences →  Medicine →  Cardiology and Cardiovascular Medicine

Related Documents

© 2026 ScienceGate Book Chapters — All rights reserved.